Airmid   Phone: (856) 905-4327
info@airmid.com
   
October 2016
October 2016 Press Release on KPI Therapeutics Presenting Positive Data at Skin Disease Conference
June 2016
June 2016 Press Release About Promising Results of Dalazatide in Lupus Study
June 2016 Fact Sheet: What Is Lupus?
January 2016
January 2016 Press Release on KPI Biotech Showcase
January 2016 Board Member George Miljanich passes
December 2015
December 2015 AIRMID Makes Board Changes
November 2015
November 2015 New Lupus Treatment Being Tested for Younger Patients

more...
 
Airmid Incorporated
Michael Pennington, Ph.D.
Chairman
2850 Mount Eden Road
Shelbyville, KY 40065
856-905-4327
 
AIRMID is seeking a committed development partner for its promising autoimmune treatment, PAP-1
Oral MULTIPLE SCLEROSIS, psoriasis AND/OR TYPE 1 DIABETES drug
SUPPOSITORY CROHN'S DISEASE drug